communicating vaccine safety
  • Photo of Mohammad Ali Mohammad Ali Korea
    Dr. Mohammad Ali (PhD) I graduated in economics from in University of Bangladesh in 1978, and started my professional life as a research analyst for the Government of Bangladesh. The research involved identifying barriers to agricultural production in Bangladesh. In late 1984, I joined the ICDDR,B, Bangladesh and worked with various health research groups coming from various parts of the world. After completion of a Master’s program in Geographic Information Sciences (GIS) at the University Liege, Belgium, I embarked on a Ph.D. program at the same university and completed it in 2000. My doctoral research focused on spatio-temporal patterns of cholera in rural Bangladesh. I have been working at the International Vaccine Institute since early 2001, and introduced GIS in vaccine evaluation studies. My newest spatial epidemiology studies investigate the effectiveness of vaccines. I demonstrate that the use of geographic variations in vaccine coverage can help evaluate the indirect protective effects of the vaccine. This new method is applicable to trials of a wide range of vaccines before they are introduced into public health practice. I am author or co-author of 120 publications, reviewer of several peer-reviewed journals, adjunct professor of Seoul National University, and Research Consultant of University of North Carolina at Chapel Hill, USA.
  • Photo of Frederic Bouder Frederic Bouder Netherlands
    Prof. Frederic Bouder (PhD) Dr. Frederic Bouder has developed policy oriented research on risk communication and risk regulation, with a strong transatlantic and comparative dimension. His research interests concentrate primarily on developing innovative models of risk communication. He has been particularly interested in the crucial concepts of acceptability and tolerability in the context of decisions that fall into the grey zone of activities linked to clear benefits but where the risks are not negligible. In 2007, he was the lead editor of “The Tolerability of Risk” which at these issues from theoretical as well as policy perspectives. Frederic Bouder has worked primarily on pharmaceutical issues, occupational safety, chemical, nuclear risks, regulatory reform and Sustainable Development. For several years Frederic Bouder was also an Administrator in the Public Governance and Territorial Development Directorate of the Organisation for Economic Co-operation and Development (OECD), a Senior Analyst for the British Sustainable Development Commission (SDC), Department for Environment, Food and Rural Affairs (DEFRA), London, United Kingdom and a National Expert at the European Medicines Agency.
  • Photo of Gabriela Codarini Gabriela Codarini Argentina
    Dr. Gabriela Codarini (MD) Maria Gabriela Codarini is an experienced pediatrician and vaccinologist dedicated to delivering the highest level of care in immunization clinics while providing state-of-the-art vaccine consultations in a safe and secure environment.After graduating for the Medical University of Buenos Aires in 1988 and pediatric residency training at the Hospital de Niños “P. De Elizalde” in Buenos Aires, Argentina, she has gained significant experience in teaching medical students and pediatric residents as a chief resident and residency program director. Dr. Codarini was also involved in the development of the distance learning program PRONAP by the Argentinian Pediatric Society, of which she has been a prominent member since 1992. For the past 10 years she has been a leading clinician and researcher at the Stamboulian Vaccination Center (Centros de Vacunación Dr. Stamboulian) in Buenos Aires, one of the largest and busiest private multi-center vaccination clinics in South America. Here she has been involved in vaccine clinical trials and research on human papillomavirus (HPV) and HIV-1 vaccines, but also in the spontaneous reporting and active surveillance of adverse events following immunization (AEFI). Dr. Codarini has presented her work at national and international meetings and symposia. In 2011, she was awarded a grant by the Argentinian Pediatric Society for the development of a prospective vaccine safety surveillance program at her Center. Her recent research has focused on the communication of vaccine risk/benefit, socioeconomic determinants of vaccine acceptance, the implementation of vaccine safety standards and immunization schedules, vaccinations in adolescents and young adults, and the teaching of vaccinology and vaccine communication to pediatric residents and practicing clinicians.
  • Photo of Chris Elemuwa Chris Elemuwa Nigeria
    Dr. Chris Elemuwa (PhD, M.Sc.) Chris Elemuwa is a graduate from the University of Lagos, Nigeria, with an Associateship Degree in Medical Laboratory Science (MLSCN) and a Bachelor and Doctorate in Public Health Microbiology. Dr. Elemuwa is currently the Deputy Director of the Laboratory and Surveillance, National Primary Health Care Development Agency in Abuja, Nigeria. Dr. Elemuwa has over 25 years of hands-on experience in laboratory science and field research. Dr. Elemuwa has exceptional know-how in healthcare delivery systems, preventive medicine, vaccine preventable disease surveillance and vaccine safety. Dr. Elemuwa also holds the degree of Master of Science (M.Sc) in Virology by the University of Ibadan, Nigeria, a Masters Degree in Immunology from Nnamdi Azikiwe University (NAU) in Anambra, Nigeria, a Masters Degree in Health Planning and Management by the University of Benin, a MLSCN fellowship degree in Hematology and Blood Transfusion Science, and a Doctorate in Public Health Microbiology by the Ambrose ALLI University, , Nigeria. Dr. Elemuwa has co-authored more than 30 peer-reviewed public health publications and is a member of several national and international professional societies. In addition to being a founding member of the Vaccine Safety Initiative Think Tank, he is also a Fellow at the Association of Medical Laboratory Scientist of Nigeria, an expert consultant to the Nigerian Healthcare Strengthening Initiative (HCSI) partnering with several national and international organizations including PATH 2 and the Federal Ministry of Health/ WHO. Throughout his career, Dr. Elemuwa has held numerous leadership positions, as a student activist as well as a professional and community leader. Dr. Elemuwa is a dedicated healthcare specialist who strongly believes in the ability to shape the future of our children by means of international collaboration, sustainable development and continuous improvement to the healthcare system in Nigeria and beyond.
  • Photo of Gerhard Gaedicke Gerhard Gaedicke Austria
    Prof. Gerhard Gaedicke (MD) Professor Gaedicke received his doctoral degree from the University of Hamburg, Germany, and his post-doctoral teaching qualification (Habilitation) from the University of Ulm, Germany, where he also completed his pediatric residency training in pediatric hematology and oncology, neonatology and pediatric intensive care. After several years as attending physician and associate professor of pediatrics at Ulm University, Dr. Gaedicke received a full professorship in pediatrics at the Humboldt University in Berlin in 1993. He became director of the department of pediatrics at the Charité University Medical Center (former East Berlin). After the fall of the Berlin wall Prof. Gaedicke was responsible for the merging of the pediatric departments of former West Berlin at Free University and of former East Berlin at Humboldt University, which came together under the common umbrella of the Charité - Otto-Heubner Center for Pediatric and Adolescent Medicine, one of the largest pediatric centers in Europe to date. Throughout his career Professor Gaedicke has been involved in international dialogue and intent on connecting cultures by means of open collaborative research at Charité and beyond, including the Scripps Research Institute in San Diego, California, and the Cancer Center at the University of Southern California. Prof. Gaedicke has served on the board of several professional associations, such as the German Society of Pediatrics (DKGJ) and The German Society for Pediatric Hematology-Oncology (GPOH) He was treasurer and a board member of the European Paediatric Association (EPA), member of the UNICEF Committee for Germany, the American Society of Hematology, the European Society for Bone Marrow Transplantation, and the German Society for Gene Therapy. After his retirement as an emeritus professor in 2009 he directed the reformed curriculum program at Charité. The innovative reformed curriculum aims at the integration of basic sciences and clinical topics from the very beginning. Teaching research skills to medical students, is as obvious as that of communication skills e.g. delicate topics such as vaccine compliance and safety. In 2012 Prof. Gaedicke has accepted the directorship of the Department of Pediatrics at the Medical University of Innsbruck, Austria.
  • Photo of Marina Galytskaya Marina Galytskaya Russia
    Marina Galytskaya (PhD) Marina Galytskaya has graduated from the Russian state medical university. In 1996 she has arrived in clinical internship of the Russian medical academy of Sciences on specialization “Neonatology“. Later (from 1998 up to 2003) she worked as the pediatrician – neonatologist in various establishments of public health services. Since 2003 year she works in Scientific Centre of Children’s Health of Russian Academy of Medical Science as the doctor-immunologist, since 2007 – as a head of the Centre of Vaccinal Prophylaxis. She is a frequent participant of the international congresses, takes part in scientifically-practical conferences with reports and lectures, writes articles in scientific journals.
  • Photo of Tatyana Grechukha Tatyana Grechukha Russia
    Dr. Tatyana Grechukha (PhD) Tatyana Grechukha was born in 1983. She graduated from the medical department of Kabardino-Balkarian State University, Russia, in 2006. Between 2006 and 2008 she worked as a pediatrician at the Scientific Centre of Children’s Health of the Russian Academy of Medical Science. From 2008 until 2011 she worked at the nephrological department of Scientific Centre of Children’s Health as a PhD student. Dr. Grechukha’s dissertation discusses the immunization against pneumococcal infection of patients with kidney diseases. Currently she is a scientific researcher at the Vaccine Prevention Clinic of Scientific Centre of Children’s Health. She actively participates in international congresses, gives lectures at scientific conferences and regularly writes articles and methodological discussions for scientific journals.
  • Photo of Daphne Holt Daphne Holt France
    Daphne Holt PhD MBA FRCPath I joined the world of charity management in 1999 after 30 years in medical research and education, first with the UK Medical Research Council and then at Imperial College in London, where from 1986 I was team leader at the Karim Centre for Meningitis Research. After working on international development for the Meningitis Trust (UK) I joined the Confederation of Meningitis Organisations (CoMO in 2009 to become the first executive director, and to establish CoMO as a registered organisation in Perth, Western Australia. CoMO now has 43 members in 28 countries around the world and I have been involved with this organisation since its inception, as a loose network of like-minded people, in 2004. During my career in science and as a charity manager I have published and presented on meningococcal disease, especially in the new-born baby. I also served on the WHO Working Group on the terms of reference for the International Coordinating Group (ICG) on Vaccine Provision for Epidemic Meningitis Control. I retired in March 2010 and have lived in France since 2001. I am now a member of the Governing Council of CoMO and hold the Vice Presidency.
  • Photo of Ali Khamesipour Ali Khamesipour Iran
    Prof. A. Khamesipour (PhD) Dr. Ali Khamesipour (PhD) is a professor at the Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, in Iran. His expertise lies in GCP clinical trials of vaccines and drugs from Phase 1 to Phase 3, experimental and clinical Immunology, protocol development, data management and ethics. After receiving his PhD from the Department of Medical Microbiology and Immunology at the School of Medicine at Southern Illinois State University in 1992, Dr. Khamesipour completed a post-doctoral fellowship at the Department of Pathology at the College of Medicine at the University of California, Irvine. Since 1993 he has been involved in the development and efficacy trials of vaccines against leishmaniasis. He is chair of the National Leishmaniasis Network and a member of a variety of professional associations, including the Editorial Board of Clinical Reviews and Opinions, the National Committee on Leishmaniasis Management, as well as the Research Council of Iran Molecular Medicine Network. Dr. Khamesipour has published over 100 articles, including contributions to the Journal of Clinical Immunology, the Journal of Tropical Pediatrics, Microbes and Infection, as well as Vaccine.
  • Photo of Sonali Kochhar Sonali Kochhar India
    Dr. Sonali Kochhar (MD) Clinical Research & Drug Development Specialist, PATH has extensive global experience in Vaccines and Drugs development for Infectious Diseases (including HIV/AIDS). She has been responsible for providing leadership for Clinical Development Strategy, Design, Implementation and Medical Oversight for international multi-centric, multi-country trials. She has provided Clinical and Regulatory support for Phase I - IV international trials for Vaccines and Drugs conducted in adult and paediatric populations in the USA, Europe, India, Africa and Asia. She has also been responsible for scientific advocacy and partnership development with International and National Government Partners, Public Health Authorities, Regulatory Bodies, Scientific Authorities, International Pharmaceutical Companies, Local Communities and the Media. She works with Government partners for National Policy and Program Development. Dr Kochhar received her M.D. in Pharmacology from Delhi University, India, has done International Advanced Vaccinology courses from the University of Geneva and Fondation Mérieux, Annecy, France (ADVAC) and Seoul, Korea (Advanced Course on Vaccinology in Asia-Pacific Region) and Epidemiology from the London School of Hygiene and Tropical Medicine. She has served as Guest Faculty for International Vaccinology and Clinical Research Professional Programs, is a member of international groups involved in the development of a WHO globally integrated Vaccine Safety Monitoring system, Safety Standards for Malaria, Tuberculosis and AIDS Vaccine trials, the Global Health Clinical Consortium Leadership Group and the Vienna Vaccine Safety Initiative working on global clinical research and safety. She was a Yale World Fellow for 2011 (Yale University’s International Leadership Program). She has been awarded the Vaccinology Fellowship Award for significant achievements in Vaccinology from Fondation Mérieux and University of Geneva; Global Leadership Awards from Eli Lilly & Company, Indianapolis, U.S.A; Bharat Jyoti (Light of India) Award for medical achievements and the Serviers Young Investigator Award by Institute de Recherches Internationales, Servier, France for Clinical Research.
  • Photo of Ruth Kutalek Ruth Kutalek Austria
    Dr. Ruth Kutalek Dr. Ruth Kutalek is a Medical Anthropologist and Associate Professor at the Center of Public Health, Medical University of Vienna. She is also lecturer at the University of Vienna and at the University of Applied Sciences Campus Vienna. Since her time as a Fulbright visiting scholar at Harvard University she has been interested and engaged in the development of curricula in various settings, specifically in introducing aspects of diversity, culture & health in the curriculum for undergraduate medical studies in Vienna, and in co-developing curricula for medical anthropology in the undergraduate studies for social and cultural anthropology in Vienna and for the Master’s course “Medical Anthropology” at Gulu University, Uganda (financed by the Austrian Development Cooperation). Her research mainly focuses on medical anthropology/ethnomedicine (indigenous health systems, health seeking behavior, especially in Tanzania), migration and health (brain drain in Africa; migrant health in Vienna), global health (anthropological perspectives on infectious diseases), medical ethics (movement of health care workers), qualitative methodology and ethnopharmacology. As a consultant she has been part of the WHO Ebola response team in Liberia in 2014 and 2015, specifically focusing on the psycho-social role of survivors and on contact tracing.
  • Photo of Wolfgang Maurer Wolfgang Maurer Austria
    Dr. Wolfgang Maurer (MD, PhD) Wolfgang Maurer has been responsible in Austria for state evaluations of vaccines and blood products in the licensure procedure, also for batch testing of vaccines and blood products, was part of regulatory bodies such as EMA (London) and European Pharmocopoiea (Strassbourg) and headed the Official Medicines Control Laboratory for vaccines and blood products (OMCL). There he was also responsible for the batch release of HIV diagnostics. He was a member of the Austrian advisory committee on immunization practices and of the AIDS committee. Dr Maurer was responsible for all aspects of vaccinology at the University Department for Paediatrics in Vienna including clinical and non-clinical research, has participated at the first Advanced Vaccinology Course in Annecy (ADVAC), and now works at the Center for Public Health (Medical University of Vienna). His research focuses primarily on vaccine safety and communication and in this context he also studies the anti-vaccine movement. He also works on clinical advice and adverse events after immunization. Dr Maurer has given over 200 presentations, talks, workshops and shown posters in many countries mostly on vaccine safety, immunology, and the anti-vaccine movement. He has over 20 publications in peer reviewed journals. Wolfgang Maurer was a member of a WHO mission in Ukraine during the Diptheria outbreak in the 1990s. He now is a lecturer at the Medical University of Vienna. Dr Maurer received his PhD in Biochemistry and his MD in Vienna University and originally specialised in Laboratory Medicine.
  • Photo of Edison Mworozi Edison Mworozi Uganda
    Dr. Edison Arwanire Mworozi (PhD) Dr. Mworozi is a medical doctor specializing in Paediatrics and Child health and is currently working as a senior consultant Paediatrician at Mulago National Referral Hospital and Honorary lecturer at the College of Health Sciences Makerere University and Uganda Martyrs University Nkozi Uganda. He graduated with an MBChB and Master of Medicine in Paediatrics and child health from Makerere University Kampala Uganda. He has received further training in epidemiology, research methodology, conducting clinical trials, good clinical practices, vaccinology and children’s environmental health. He is a member of the Uganda Medical Board, National Expert committee on Child Health in Uganda, East African Rotavirus Advisory Board& a consultant to GSK. He is also a member of Institutional Biosafety committees for the Makerere University and Walter Reed Collaborative HIV Vaccine Trials and Makerere University John`s Hopkins collaborative HIV Vaccine Trials. He is currently involved in Malaria Vaccine clinical trials. He has vast experience in training at both undergraduate and graduate levels and has carried out research at both health facility and community levels. He has published several articles especially on Pediatric infectious diseases in peer reviewed journals and has been a peer reviewer for a number of journals. He has received a number of Excellency awards for his contribution to Child Health and survival. From 1980 -1989 he worked at Mulago National referral& teaching Hospital as a medical officer & registrar. From 1989-1995 and from 1995-2006 he worked at the same hospital &the College of Health sciences Makerere University as a senior registrar/ honorary lecturer and consultant/honorary lecturer respectively. From 2006 to date He has worked at the same institutions as senior Consultant /Honorary lecturer. From 2001 to November he was acting head of Department of Paediatrics and Child health Makerere University and clinical Head department of Pediatrics Mulago National referral hospital from 2006-2007.He has great interest ,understanding and is involved in the Uganda National immunization programs where he gives technical advice and support. He has keen interest in new vaccines for Global health and is playing a key role in advocating for the introduction of new vaccines such as Rotavirus, Pneumococcal, and HPV vaccines in Uganda. He has attended and participated in a number of vaccination related courses /meetings including the Advanced Course of Vaccinology conducted by the University of Geneva and Fondation Merieux, May 2012 Annecy France, the Royal Social Society Discussion meeting on New Vaccines for Global Health November 2010 London and Satellite meeting on Accelerating Vaccine Development November 2010at the Kavli International Centre Buchinghamshire UK.
  • Photo of Barbara Rath Barbara Rath Germany
    Dr. Barbara A. Rath (MD, PhD) Dr. Barbara Rath is a board-certified pediatric consultant and infectious disease specialist with 20 years experience in clinical trials, public health and virology in the US, Latin America and Europe. Dr. Rath is honorary professor at the University of Nottingham School of Medicine, UK and board member at the International Society for Influenza and other Respiratory Viruses (ISIRV). Dr. Rath received her medical school education in Germany, the United States and Spain, and her doctoral degrees from the University of Basel, Switzerland and the University of Besançon, France. In addition to a post-doctoral fellowship at the Stanford Department of Medicine, Division of Infectious Diseases & Geographic Medicine, she has received pediatric residency and infectious disease subspecialty training at Duke and Tulane Universities, USA. Recent research focuses on defining a precision medicine approach to managing pediatric patients with acute viral infections. In collaboration with the Robert Koch Institute she developed innovative real-time surveillance programs for the monitoring of influenza-like illness and the immuno-safety of vaccines and antivirals in infants and children. Dr. Rath is co-founder and chair of the Vienna Vaccine Safety Initiative, an international think tank and non-profit-organization focused on new avenues for the treatment, communication and prevention of infectious diseases. Her team developed and validated clinical and virologic endpoints for clinical trials and observational settings. The goal is to individualize the management of influenza and other respiratory viral infections though integration of infectious disease epidemiology with data standardization, mobile health, biomarker research and advanced diagnostic capabilities. The Vienna Vaccine Safety Initiative consults and collaborates on a regular basis with experts in risk communication, global health, design thinking, population science, health policy, bioethics and regulatory science. The Vienna Vaccine Safety Initiative is a founding member of the International Association of Innovation Professionals and an institutional member of the European Forum for Good Clinical Practice.
  • Photo of Julie Renahy Julie Renahy France
    Dr. Julie Renahy (PhD) Dr Julie Renahy (PhD) is a young entrepreneur and a linguist at the University of Franche-Comté (Besançon, France). She was one of the main researchers of the Project LiSe (« Linguistique, normes, traitement automatique des langues et sécurité), a research project funded by the French National Research Agency (ANR), coordinated by the University of Franche-Comté, with Airbus Company as a partner. She is the project leader of the spin-off Univoca, a company-to-be, the aim of which is to offer controlled language writing services and to develop and commercialize Controlled Language writing software solutions. The creation of the company is expected in March 2011.
  • Photo of Gabriella Rundblad Gabriella Rundblad Great Britain
    Dr. Gabriella Rundblad (PhD) Gabriella Rundblad is Lecturer in Applied Linguistics at King's College London, specialising in the interface between language, cognition and behaviour. She has been PI on three recent projects investigating communication about drinking water. Her research explores authority, factuality, and impersonalisation in different types of lay/professional health discourse, including government/non-government websites and media reports on immunisation, as well as the discourse of medical research articles. Work on health communication has allowed her to develop a new text analysis approach, Cognitive Discourse Analysis, which draws upon Critical Discourse Analysis, Systemic Functional Linguistics and Frame Semantics. Dr Rundblad also studies the language and cognitive development of children/adults with/without language disorders.
  • Photo of Brett Trusko Brett Trusko USA
    Prof. Brett Trusko (PhD, MBA) Dr. Brett Trusko is an Assistant Professor of Medicine at Mount Sinai School of Medicine at NYU in New York City. He is also the Executive Director of the Texas Institute for Smart Health and adjunct faculty at Baylor College of Medicine. In this position he performs research on utilizing innovation, technology and process improvement to optimize the healthcare experience. Dr. Trusko is also the Editor-in-Chief of the International Journal of Innovation Science. In this position, he is building the subscriber base, editing all submissions and managing this 3-year old academic journal focused on the science and methods of innovation. He is a professional speaker and corporate facilitator. He is a featured speaker on and through his consulting company, IRC, Inc. he facilitates board and corporate retreats. His speaking activities include “The Future of . . . “ varies industries, improving quality and creating the innovative organization. He has a PhD in Business Administration and Technology Management and has over 30 years of experience including innovation, quality, strategy, informatics, operations, and administration. He is a certified project manager and a certified Six Sigma Master Black Belt as well as practitioner in “Lean” methods. His focus throughout his career has been on harnessing human innovation to capture the potential of technology in the improvement of business. In the spring of 2007 Dr. Trusko published “Improving Healthcare Quality and Cost with Six Sigma.” He has also contributed chapters to several other books on compliance and quality and has been published over 200 times in various magazines and academic journals. He is considered a global leader in healthcare quality and technology where he utilizes patient and family centered approaches to the evaluation of quality. He is currently under contract to produce “The Innovation Handbook“ and “The Value Proposition”.
  • Photo of Dominique A. Vuitton Dominique A. Vuitton France
    Prof. Dominique Angèle Vuitton (MD, PhD) Prof. Vuitton is Professor Emeritus in Clinical Immunology at the University of Franche-Comté (Besançon, France). She was Vice-President, in charge of research, of the University of Franche-Comté and Head of the WHO Collaborating Center on Prevention and Treatment of Human Echinococcosis. She has shown a great interest in linguistics for many years and was one of the main medical researchers of the Project LiSe (« Linguistique, normes, traitement automatique des langues et sécurité), a research project funded by the French National Research Agency (ANR), coordinated by the University of Franche-Comté, with Airbus Company as a partner. Executive director of “Vuitton Consultant”, a small company involved in research project management, and scientific expert for the European Commission DG Research and EFSA, she also took part in the creation of Prolipsia, a company which offers controlled language writing services and develops as well as commercializes controlled language writing software solutions.